In the case of TIPARP, we found that in agreement with previous reports on breast cancer cells (Rasmussen et al., 2021), expression levels were increased by E2 (pretreated vs. non-pretreated cells) and apparently by R5020 as well (treated vs. untreated conditions). This evidence concerns the gene TIPARP and breast carcinoma.